These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 16206491)

  • 41. Defense mechanisms in inflammatory bowel disease.
    Hyphantis TN; Triantafillidis JK; Pappa S; Mantas C; Kaltsouda A; Cherakakis P; Alamanos Y; Manousos ON; Mavreas VG
    J Gastroenterol; 2005 Jan; 40(1):24-30. PubMed ID: 15692786
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Extraintestinal considerations in inflammatory bowel disease.
    Levine JB; Lukawski-Trubish D
    Gastroenterol Clin North Am; 1995 Sep; 24(3):633-46. PubMed ID: 8809240
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acquired protein C and S deficiency, inflammatory bowel disease and cerebral arterial thrombosis.
    Jorens PG; Hermans CR; Haber I; Kockx MM; Vermylen J; Parizel GA
    Blut; 1990 Nov; 61(5):307-10. PubMed ID: 2148695
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Etiology and pathophysiology of inflammatory bowel disease--environmental factors.
    Andus T; Gross V
    Hepatogastroenterology; 2000; 47(31):29-43. PubMed ID: 10690583
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mechanisms and efficacy of immunobiologic therapies for inflammatory bowel diseases.
    Ghosh N; Chaki R; Mandal V; Lin GD; Mandal SC
    Int Rev Immunol; 2010; 29(1):4-37. PubMed ID: 20100080
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Thrombosis in inflammatory bowel diseases: role of inherited thrombophilia.
    Spina L; Saibeni S; Battaglioli T; Peyvandi F; de Franchis R; Vecchi M
    Am J Gastroenterol; 2005 Sep; 100(9):2036-41. PubMed ID: 16128949
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inflammatory bowel disease in children--clinical, endoscopic, radiologic and histopathologic investigation.
    Seo JK; Yeon KM; Chi JG
    J Korean Med Sci; 1992 Sep; 7(3):221-35. PubMed ID: 1285921
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inflammatory bowel disease.
    Knigge KL
    Clin Cornerstone; 2002; 4(4):49-60. PubMed ID: 12739326
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inflammatory bowel disease.
    Martins NB; Peppercorn MA
    Am J Manag Care; 2004 Aug; 10(8):544-52. PubMed ID: 15352530
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence and pathogenesis of osteoporosis in patients with inflammatory bowel disease.
    Vestergaard P
    Minerva Med; 2004 Dec; 95(6):469-80. PubMed ID: 15785432
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease.
    Satsangi J; Welsh KI; Bunce M; Julier C; Farrant JM; Bell JI; Jewell DP
    Lancet; 1996 May; 347(9010):1212-7. PubMed ID: 8622450
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Venous thrombosis in inflammatory bowel disease.
    Srirajaskanthan R; Winter M; Muller AF
    Eur J Gastroenterol Hepatol; 2005 Jul; 17(7):697-700. PubMed ID: 15947544
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Coagulation factor XIII and markers of thrombin generation and fibrinolysis in patients with inflammatory bowel disease.
    Hayat M; Ariëns RA; Moayyedi P; Grant PJ; O'Mahony S
    Eur J Gastroenterol Hepatol; 2002 Mar; 14(3):249-56. PubMed ID: 11953689
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Frequency of detection of some markers of endothelial dysfunction in patients with inflammatory bowel diseases.
    Babayeva GH; Babayev ZM
    Ter Arkh; 2018 Apr; 90(4):12-16. PubMed ID: 30701868
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of cytokines and platelet-activating factor in inflammatory bowel disease. Implications for therapy.
    Nassif A; Longo WE; Mazuski JE; Vernava AM; Kaminski DL
    Dis Colon Rectum; 1996 Feb; 39(2):217-23. PubMed ID: 8620791
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevention and therapeutic strategies of thromboembolic events in patients with inflammatory bowel diseases: a report of three cases.
    Włodarczyk M; Sobolewska A; Fichna J; Wiśniewska-Jarosińska M
    Curr Drug Targets; 2015; 16(3):194-8. PubMed ID: 25382207
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hemostatic abnormalities in inflammatory bowel disease.
    Chiarantini E; Valanzano R; Liotta AA; Cellai AP; Fedi S; Ilari I; Prisco D; Tonelli F; Abbate R
    Thromb Res; 1996 Apr; 82(2):137-46. PubMed ID: 9163067
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical and experimental evidence of sympathetic neural dysfunction during inflammatory bowel disease.
    Boissé L; Chisholm SP; Lukewich MK; Lomax AE
    Clin Exp Pharmacol Physiol; 2009 Oct; 36(10):1026-33. PubMed ID: 19566829
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bone density improves with disease remission in patients with inflammatory bowel disease.
    Reffitt DM; Meenan J; Sanderson JD; Jugdaohsingh R; Powell JJ; Thompson RP
    Eur J Gastroenterol Hepatol; 2003 Dec; 15(12):1267-73. PubMed ID: 14624148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.